Vaccine sputum heats up as AstraZeneca confirms plans for negotiations with the EU | News on the coronavirus pandemic

0
19

[ad_1]

Talks between AstraZeneca and the EU raise concerns over vaccine nationalism, as nations battle for limited supplies.

The European Union’s dispute with AstraZeneca escalated on Wednesday, with the Anglo-Swedish drug maker denying the EU’s claim it had withdrawn from negotiations over the supply of COVID-19 vaccines.

AstraZeneca said in a statement that it still plans to meet with EU officials in Brussels later today. The comments came after EU officials said the company informed the bloc it would not be attending a meeting to discuss the delayed vaccine commitments – the third of those talks in as many days.

“The representative of AstraZeneca had announced this morning, had informed us this morning, that their participation is not confirmed, does not happen”, declared Dana Spinant, the spokesperson for the European Commission.

The row between AstraZeneca and the EU has raised concerns over vaccine nationalism, as countries desperately want to end the coronavirus pandemic and return to normal for a limited supply of the precious vaccines.

The latest disagreement between the two sides came after AstraZeneca dismissed the EU’s accusation that the company had not honored its commitments to deliver coronavirus vaccines. AstraZeneca said the figures in its contract with the EU were targets that could not be met due to problems with the rapid expansion of production capacity.

Managing Director Pascal Soriot made the comments in an interview with Italian newspaper La Repubblica after days of criticism from European executives furious at news that AstraZeneca’s initial shipments were lower than expected.

The Anglo-Swedish drugmaker said last week that it plans to cut initial EU deliveries to 31 million doses from 80 million due to declining efficiency in the manufacturing process.

“Our contract is not a contractual commitment,” Soriot said. “It’s a better effort. Basically we said we were going to do our best, but we can’t guarantee that we will be successful. In fact, to get there, we are a little late.

AstraZeneca said in a statement that it understands and shares “the frustration that the initial supply volumes of our vaccine delivered to the European Union are lower than expected.”

On Monday, the EU threatened to impose strict export controls on COVID-19 vaccines made in the bloc within days.

The EU, which has 450 million citizens and the economic and political weight of the world’s largest trading bloc, lags far behind countries like Israel and the UK in rolling out coronavirus vaccines for its citizens. health workers and the most vulnerable. And this, despite more than 400,000 confirmed virus deaths since the start of the pandemic.

The shortfall in planned deliveries of the AstraZeneca vaccine comes at the same time as a slowdown in the distribution of Pfizer-BioNTech injections as this company modernizes the production facilities of a factory in Belgium.



[ad_2]

LEAVE A REPLY

Please enter your comment!
Please enter your name here